JP2006520330A - グアニジン誘導体および神経ペプチドｆｆ受容体拮抗物質としてのそれらの使用 - Google Patents

Info

Publication number

JP2006520330A

JP2006520330A JP2006504158A JP2006504158A JP2006520330A JP 2006520330 A JP2006520330 A JP 2006520330A JP 2006504158 A JP2006504158 A JP 2006504158A JP 2006504158 A JP2006504158 A JP 2006504158A JP 2006520330 A JP2006520330 A JP 2006520330A

Authority

JP

Japan

Prior art keywords

tetrahydro

guanidine

benzothiazol

thiazolo

formate salt

Prior art date

2003-03-20

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 150000002357 guanidines Chemical class 0.000 title claims abstract description 9
• 102000011015 Neuropeptide FF receptor Human genes 0.000 title abstract description 12
• 108010061550 Neuropeptide FF receptor Proteins 0.000 title abstract description 12
• 239000002464 receptor antagonist Substances 0.000 title abstract description 10
• 229940044551 receptor antagonist Drugs 0.000 title abstract description 10
• 229940083094 guanine derivative acting on arteriolar smooth muscle Drugs 0.000 title abstract description 5
• 150000001875 compounds Chemical class 0.000 claims abstract description 126
• 150000003839 salts Chemical class 0.000 claims abstract description 28
• 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 27
• 239000002253 acid Substances 0.000 claims abstract description 23
• 125000001424 substituent group Chemical group 0.000 claims abstract description 22
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 18
• 150000002148 esters Chemical class 0.000 claims abstract description 13
• 239000003814 drug Substances 0.000 claims abstract description 10
• 239000001257 hydrogen Substances 0.000 claims abstract description 10
• 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 10
• 239000012453 solvate Substances 0.000 claims abstract description 10
• FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims abstract description 8
• 150000007514 bases Chemical class 0.000 claims abstract description 8
• 150000004677 hydrates Chemical class 0.000 claims abstract description 7
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 5
• -1 arylalkanoyl Chemical group 0.000 claims description 158
• 150000004675 formic acid derivatives Chemical class 0.000 claims description 81
• 125000000217 alkyl group Chemical group 0.000 claims description 38
• 125000003118 aryl group Chemical group 0.000 claims description 25
• OKGXJRGLYVRVNE-UHFFFAOYSA-N diaminomethylidenethiourea Chemical compound NC(N)=NC(N)=S OKGXJRGLYVRVNE-UHFFFAOYSA-N 0.000 claims description 20
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 17
• 208000002193 Pain Diseases 0.000 claims description 14
• 125000003342 alkenyl group Chemical group 0.000 claims description 14
• 125000003710 aryl alkyl group Chemical group 0.000 claims description 13
• 238000000034 method Methods 0.000 claims description 13
• 238000002360 preparation method Methods 0.000 claims description 13
• 230000036407 pain Effects 0.000 claims description 12
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
• 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 11
• 125000004093 cyano group Chemical group *C#N 0.000 claims description 11
• 238000004519 manufacturing process Methods 0.000 claims description 11
• 238000011282 treatment Methods 0.000 claims description 11
• 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 10
• 125000000753 cycloalkyl group Chemical group 0.000 claims description 10
• 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 10
• 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 claims description 9
• 125000000304 alkynyl group Chemical group 0.000 claims description 9
• 125000004966 cyanoalkyl group Chemical group 0.000 claims description 9
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 9
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 8
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 8
• 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 7
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
• 229910052799 carbon Inorganic materials 0.000 claims description 6
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
• UELDUEAYRHAPRG-UHFFFAOYSA-N 2-(diaminomethylideneamino)-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxylic acid Chemical compound OC(=O)C1CCCC2=C1N=C(NC(=N)N)S2 UELDUEAYRHAPRG-UHFFFAOYSA-N 0.000 claims description 5
• 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 5
• 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 5
• 125000004415 heterocyclylalkyl group Chemical group 0.000 claims description 5
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 5
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 5
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 5
• 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 5
• OYRIEZNQPFTEKZ-UHFFFAOYSA-N tert-butyl 2-(diaminomethylideneamino)-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridine-5-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC2=C1SC(NC(N)=N)=N2 OYRIEZNQPFTEKZ-UHFFFAOYSA-N 0.000 claims description 5
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 5
• 208000007271 Substance Withdrawal Syndrome Diseases 0.000 claims description 4
• ABBZJHFBQXYTLU-UHFFFAOYSA-N but-3-enamide Chemical compound NC(=O)CC=C ABBZJHFBQXYTLU-UHFFFAOYSA-N 0.000 claims description 4
• 239000003792 electrolyte Substances 0.000 claims description 4
• 230000008030 elimination Effects 0.000 claims description 4
• 238000003379 elimination reaction Methods 0.000 claims description 4
• YIXNBCRNHLMGKU-UHFFFAOYSA-N ethyl 2-(diaminomethylideneamino)-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxylate Chemical compound C1C(C(=O)OCC)CCC2=C1SC(NC(N)=N)=N2 YIXNBCRNHLMGKU-UHFFFAOYSA-N 0.000 claims description 4
• 230000037406 food intake Effects 0.000 claims description 4
• 235000012631 food intake Nutrition 0.000 claims description 4
• 125000001072 heteroaryl group Chemical group 0.000 claims description 4
• 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 4
• 230000006386 memory function Effects 0.000 claims description 4
• 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
• 229940127557 pharmaceutical product Drugs 0.000 claims description 4
• DDMZPDGUXYIEAU-UHFFFAOYSA-N 2-(5-hexyl-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-2-yl)guanidine Chemical compound C1N(CCCCCC)CCC2=C1SC(NC(N)=N)=N2 DDMZPDGUXYIEAU-UHFFFAOYSA-N 0.000 claims description 3
• QDOXNVJQBUENNN-UHFFFAOYSA-N 2-(6-propan-2-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)guanidine Chemical compound C1C(C(C)C)CCC2=C1SC(NC(N)=N)=N2 QDOXNVJQBUENNN-UHFFFAOYSA-N 0.000 claims description 3
• IQSJJHUZFHAQCL-UHFFFAOYSA-N 2-(diaminomethylideneamino)-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxylic acid Chemical compound C1CC(C(O)=O)CC2=C1N=C(NC(=N)N)S2 IQSJJHUZFHAQCL-UHFFFAOYSA-N 0.000 claims description 3
• GYHPCMXILICUER-UHFFFAOYSA-N 2-[4-(aminomethyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]guanidine Chemical compound NCC1CCCC2=C1N=C(NC(N)=N)S2 GYHPCMXILICUER-UHFFFAOYSA-N 0.000 claims description 3
• 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 claims description 3
• 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 3
• 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 3
• 208000004454 Hyperalgesia Diseases 0.000 claims description 3
• 208000035154 Hyperesthesia Diseases 0.000 claims description 3
• 206010046543 Urinary incontinence Diseases 0.000 claims description 3
• 206010048010 Withdrawal syndrome Diseases 0.000 claims description 3
• 125000005115 alkyl carbamoyl group Chemical group 0.000 claims description 3
• 125000005116 aryl carbamoyl group Chemical group 0.000 claims description 3
• 125000004321 azepin-2-yl group Chemical group [H]N1C([H])=C([H])C([H])=C([H])C([H])=C1* 0.000 claims description 3
• DCGJECYGJUQGCL-UHFFFAOYSA-N benzyl 2-(diaminomethylideneamino)-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridine-5-carboxylate Chemical compound C1C=2SC(NC(=N)N)=NC=2CCN1C(=O)OCC1=CC=CC=C1 DCGJECYGJUQGCL-UHFFFAOYSA-N 0.000 claims description 3
• 125000001589 carboacyl group Chemical group 0.000 claims description 3
• 125000000392 cycloalkenyl group Chemical group 0.000 claims description 3
• TWUFTVMULHEFJW-UHFFFAOYSA-N ethyl 2-(diaminomethylideneamino)-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxylate Chemical compound CCOC(=O)C1CCCC2=C1N=C(NC(N)=N)S2 TWUFTVMULHEFJW-UHFFFAOYSA-N 0.000 claims description 3
• 125000004446 heteroarylalkyl group Chemical group 0.000 claims description 3
• 230000003914 insulin secretion Effects 0.000 claims description 3
• 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 3
• YFAYZKDRBXKNLV-UHFFFAOYSA-N n-benzyl-2-(diaminomethylideneamino)-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxamide Chemical compound C1CCC=2SC(NC(=N)N)=NC=2C1C(=O)NCC1=CC=CC=C1 YFAYZKDRBXKNLV-UHFFFAOYSA-N 0.000 claims description 3
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
• 238000007363 ring formation reaction Methods 0.000 claims description 3
• 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
• 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
• WUUADCHFBLXQKF-UHFFFAOYSA-N 2-(4,4-dimethyl-6,7-dihydro-5h-1,3-benzothiazol-2-yl)guanidine Chemical compound CC1(C)CCCC2=C1N=C(NC(N)=N)S2 WUUADCHFBLXQKF-UHFFFAOYSA-N 0.000 claims description 2
• FUGBYHUCJPEPJR-UHFFFAOYSA-N 2-(4-benzyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)guanidine Chemical compound C1CCC=2SC(NC(=N)N)=NC=2C1CC1=CC=CC=C1 FUGBYHUCJPEPJR-UHFFFAOYSA-N 0.000 claims description 2
• NDKWSGBHKXFNCC-UHFFFAOYSA-N 2-(4-butan-2-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)guanidine Chemical compound CCC(C)C1CCCC2=C1N=C(NC(N)=N)S2 NDKWSGBHKXFNCC-UHFFFAOYSA-N 0.000 claims description 2
• QSOMFWDDWOFLBS-UHFFFAOYSA-N 2-(4-ethyl-4-methyl-6,7-dihydro-5h-1,3-benzothiazol-2-yl)guanidine Chemical compound CCC1(C)CCCC2=C1N=C(NC(N)=N)S2 QSOMFWDDWOFLBS-UHFFFAOYSA-N 0.000 claims description 2
• OYBQOMBJSHYEAL-UHFFFAOYSA-N 2-(4-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)guanidine Chemical compound CC1CCCC2=C1N=C(NC(N)=N)S2 OYBQOMBJSHYEAL-UHFFFAOYSA-N 0.000 claims description 2
• LYLYGOUPJRCBLS-UHFFFAOYSA-N 2-(4-methyl-4-propyl-6,7-dihydro-5h-1,3-benzothiazol-2-yl)guanidine Chemical compound CCCC1(C)CCCC2=C1N=C(NC(N)=N)S2 LYLYGOUPJRCBLS-UHFFFAOYSA-N 0.000 claims description 2
• BYPPQYJAMBPADG-UHFFFAOYSA-N 2-(4-phenyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)guanidine Chemical compound C1CCC=2SC(NC(=N)N)=NC=2C1C1=CC=CC=C1 BYPPQYJAMBPADG-UHFFFAOYSA-N 0.000 claims description 2
• ALIMGROCSLBETQ-UHFFFAOYSA-N 2-(4-tert-butyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)guanidine Chemical compound CC(C)(C)C1CCCC2=C1N=C(NC(N)=N)S2 ALIMGROCSLBETQ-UHFFFAOYSA-N 0.000 claims description 2
• UCXUJAFVTACPGW-UHFFFAOYSA-N 2-(4-tert-butyl-6-phenyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)guanidine Chemical compound C1C=2SC(NC(N)=N)=NC=2C(C(C)(C)C)CC1C1=CC=CC=C1 UCXUJAFVTACPGW-UHFFFAOYSA-N 0.000 claims description 2
• QXOFHSUKWFCEBI-UHFFFAOYSA-N 2-(5,5,7,7-tetramethyl-4,6-dihydro-1,3-benzothiazol-2-yl)guanidine Chemical compound CC1(C)CC(C)(C)CC2=C1SC(NC(N)=N)=N2 QXOFHSUKWFCEBI-UHFFFAOYSA-N 0.000 claims description 2
• WLACEDJDTIXJHA-UHFFFAOYSA-N 2-(5,5,7-trimethyl-6,7-dihydro-4h-1,3-benzothiazol-2-yl)guanidine Chemical compound CC1CC(C)(C)CC2=C1SC(NC(N)=N)=N2 WLACEDJDTIXJHA-UHFFFAOYSA-N 0.000 claims description 2
• KLFUHWVGNPXLLK-UHFFFAOYSA-N 2-(5,5-dimethyl-6,7-dihydro-4h-1,3-benzothiazol-2-yl)guanidine Chemical compound C1C(C)(C)CCC2=C1N=C(NC(N)=N)S2 KLFUHWVGNPXLLK-UHFFFAOYSA-N 0.000 claims description 2
• JVACMLRJYVWKJM-UHFFFAOYSA-N 2-(5,5-dimethyl-6-phenyl-6,7-dihydro-4h-1,3-benzothiazol-2-yl)guanidine Chemical compound CC1(C)CC=2N=C(NC(N)=N)SC=2CC1C1=CC=CC=C1 JVACMLRJYVWKJM-UHFFFAOYSA-N 0.000 claims description 2
• UFTXCRWHCXBQKN-UHFFFAOYSA-N 2-(5,6,7,8-tetrahydro-4h-cyclohepta[d][1,3]thiazol-2-yl)guanidine Chemical compound C1CCCCC2=C1N=C(NC(=N)N)S2 UFTXCRWHCXBQKN-UHFFFAOYSA-N 0.000 claims description 2
• UAIBRYGHVVYQBK-UHFFFAOYSA-N 2-(5,6-dihydro-4h-cyclopenta[d][1,3]thiazol-2-yl)guanidine Chemical compound C1CCC2=C1N=C(NC(=N)N)S2 UAIBRYGHVVYQBK-UHFFFAOYSA-N 0.000 claims description 2
• FSWGIXWSQKVRBR-UHFFFAOYSA-N 2-(5-benzyl-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-2-yl)guanidine Chemical compound C1C=2SC(NC(=N)N)=NC=2CCN1CC1=CC=CC=C1 FSWGIXWSQKVRBR-UHFFFAOYSA-N 0.000 claims description 2
• LNXDWHDZNHLNAB-UHFFFAOYSA-N 2-(5-butyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)guanidine Chemical compound C1C(CCCC)CCC2=C1N=C(NC(N)=N)S2 LNXDWHDZNHLNAB-UHFFFAOYSA-N 0.000 claims description 2
• GMABAPWOAXNDDE-UHFFFAOYSA-N 2-(5-butyl-5,6,7,8-tetrahydro-4h-cyclohepta[d][1,3]thiazol-2-yl)guanidine Chemical compound C1C(CCCC)CCCC2=C1N=C(NC(N)=N)S2 GMABAPWOAXNDDE-UHFFFAOYSA-N 0.000 claims description 2
• UPEQOVLNRJIVEL-UHFFFAOYSA-N 2-(5-butylsulfonyl-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-2-yl)guanidine Chemical compound C1N(S(=O)(=O)CCCC)CCC2=C1SC(NC(N)=N)=N2 UPEQOVLNRJIVEL-UHFFFAOYSA-N 0.000 claims description 2
• ZYPREDXHNDNTCV-UHFFFAOYSA-N 2-(5-ethyl-5-methyl-6,7-dihydro-4h-1,3-benzothiazol-2-yl)guanidine Chemical compound C1C(CC)(C)CCC2=C1N=C(NC(N)=N)S2 ZYPREDXHNDNTCV-UHFFFAOYSA-N 0.000 claims description 2
• YFOHSVMOPDQBTG-UHFFFAOYSA-N 2-(5-ethyl-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-2-yl)guanidine Chemical compound C1N(CC)CCC2=C1SC(NC(N)=N)=N2 YFOHSVMOPDQBTG-UHFFFAOYSA-N 0.000 claims description 2
• RDQBDBMPQLZPSN-UHFFFAOYSA-N 2-(5-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)guanidine Chemical compound C1C(C)CCC2=C1N=C(NC(N)=N)S2 RDQBDBMPQLZPSN-UHFFFAOYSA-N 0.000 claims description 2
• ICDGFGKAIBXUJJ-UHFFFAOYSA-N 2-(5-methyl-5-phenyl-6,7-dihydro-4h-1,3-benzothiazol-2-yl)guanidine Chemical compound C1CC=2SC(NC(N)=N)=NC=2CC1(C)C1=CC=CC=C1 ICDGFGKAIBXUJJ-UHFFFAOYSA-N 0.000 claims description 2
• RHNOCHLHOYFGLC-UHFFFAOYSA-N 2-(5-methylsulfonyl-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-2-yl)guanidine Chemical compound C1N(S(=O)(=O)C)CCC2=C1SC(NC(N)=N)=N2 RHNOCHLHOYFGLC-UHFFFAOYSA-N 0.000 claims description 2
• BQTZVYKQEGHYIG-UHFFFAOYSA-N 2-(5-pentanoyl-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-2-yl)guanidine Chemical compound C1N(C(=O)CCCC)CCC2=C1SC(NC(N)=N)=N2 BQTZVYKQEGHYIG-UHFFFAOYSA-N 0.000 claims description 2
• AOCYGZXXCPMOJM-UHFFFAOYSA-N 2-(5-phenyl-5,6,7,8-tetrahydro-4h-cyclohepta[d][1,3]thiazol-2-yl)guanidine Chemical compound C1CCC=2SC(NC(=N)N)=NC=2CC1C1=CC=CC=C1 AOCYGZXXCPMOJM-UHFFFAOYSA-N 0.000 claims description 2
• JWSONFTVEHCGJQ-UHFFFAOYSA-N 2-(5-propan-2-ylsulfonyl-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-2-yl)guanidine Chemical compound C1N(S(=O)(=O)C(C)C)CCC2=C1SC(NC(N)=N)=N2 JWSONFTVEHCGJQ-UHFFFAOYSA-N 0.000 claims description 2
• FBUBOFVNIZACRW-UHFFFAOYSA-N 2-(5-propyl-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-2-yl)guanidine Chemical compound C1N(CCC)CCC2=C1SC(NC(N)=N)=N2 FBUBOFVNIZACRW-UHFFFAOYSA-N 0.000 claims description 2
• AKOBTVQNQFUIFL-UHFFFAOYSA-N 2-(6,6-dimethyl-5,7-dihydro-4h-1,3-benzothiazol-2-yl)guanidine Chemical compound C1C(C)(C)CCC2=C1SC(NC(N)=N)=N2 AKOBTVQNQFUIFL-UHFFFAOYSA-N 0.000 claims description 2
• WVXCYAIRSGWGBV-UHFFFAOYSA-N 2-(6,6-diphenyl-5,7-dihydro-4h-1,3-benzothiazol-2-yl)guanidine Chemical compound C1C=2SC(NC(=N)N)=NC=2CCC1(C=1C=CC=CC=1)C1=CC=CC=C1 WVXCYAIRSGWGBV-UHFFFAOYSA-N 0.000 claims description 2
• CYXYEESUXIALNC-UHFFFAOYSA-N 2-(6,7-dihydro-4h-pyrano[4,3-d][1,3]thiazol-2-yl)guanidine Chemical compound C1COCC2=C1N=C(NC(=N)N)S2 CYXYEESUXIALNC-UHFFFAOYSA-N 0.000 claims description 2
• MCCUUZYXCGYWIN-UHFFFAOYSA-N 2-(6-cyano-6-phenyl-5,7-dihydro-4h-1,3-benzothiazol-2-yl)guanidine Chemical compound C1C=2SC(NC(=N)N)=NC=2CCC1(C#N)C1=CC=CC=C1 MCCUUZYXCGYWIN-UHFFFAOYSA-N 0.000 claims description 2
• GUWOIUDVUADBQM-UHFFFAOYSA-N 2-(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)guanidine Chemical compound C1C(C)CCC2=C1SC(NC(N)=N)=N2 GUWOIUDVUADBQM-UHFFFAOYSA-N 0.000 claims description 2
• WPRMMSUIODPDQQ-UHFFFAOYSA-N 2-(6-phenyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)guanidine Chemical compound C1C=2SC(NC(=N)N)=NC=2CCC1C1=CC=CC=C1 WPRMMSUIODPDQQ-UHFFFAOYSA-N 0.000 claims description 2
• GGSJEFBOSRYGBZ-UHFFFAOYSA-N 2-(6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)guanidine Chemical compound C1C(CCC)CCC2=C1SC(NC(N)=N)=N2 GGSJEFBOSRYGBZ-UHFFFAOYSA-N 0.000 claims description 2
• RFZXGFBVQUEHCE-UHFFFAOYSA-N 2-(6-tert-butyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)guanidine Chemical compound C1C(C(C)(C)C)CCC2=C1SC(NC(N)=N)=N2 RFZXGFBVQUEHCE-UHFFFAOYSA-N 0.000 claims description 2
• XHPLIMKFVJUFOQ-UHFFFAOYSA-N 2-(6-thiophen-2-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)guanidine Chemical compound C1C=2SC(NC(=N)N)=NC=2CCC1C1=CC=CS1 XHPLIMKFVJUFOQ-UHFFFAOYSA-N 0.000 claims description 2
• WVIAKQLSKCZTNT-UHFFFAOYSA-N 2-(7-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)guanidine Chemical compound CC1CCCC2=C1SC(NC(N)=N)=N2 WVIAKQLSKCZTNT-UHFFFAOYSA-N 0.000 claims description 2
• LTLRBTVKAFNNIM-UHFFFAOYSA-N 2-(diaminomethylideneamino)-n,n-di(propan-2-yl)-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxamide Chemical compound CC(C)N(C(C)C)C(=O)C1CCCC2=C1N=C(NC(N)=N)S2 LTLRBTVKAFNNIM-UHFFFAOYSA-N 0.000 claims description 2
• VSXRAZUNVFIEQE-UHFFFAOYSA-N 2-(diaminomethylideneamino)-n,n-dipropyl-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxamide Chemical compound CCCN(CCC)C(=O)C1CCCC2=C1N=C(NC(N)=N)S2 VSXRAZUNVFIEQE-UHFFFAOYSA-N 0.000 claims description 2
• GOJROTMNJNWGMG-UHFFFAOYSA-N 2-(diaminomethylideneamino)-n-(1-methoxypropan-2-yl)-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridine-5-carbothioamide Chemical compound C1N(C(=S)NC(C)COC)CCC2=C1SC(NC(N)=N)=N2 GOJROTMNJNWGMG-UHFFFAOYSA-N 0.000 claims description 2
• SLQUKKCTGQRJSM-UHFFFAOYSA-N 2-(diaminomethylideneamino)-n-(3-methylbutyl)-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxamide Chemical compound C1C(C(=O)NCCC(C)C)CCC2=C1SC(NC(N)=N)=N2 SLQUKKCTGQRJSM-UHFFFAOYSA-N 0.000 claims description 2
• YHBVQQYSGAVNFE-UHFFFAOYSA-N 2-(diaminomethylideneamino)-n-pentyl-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridine-5-carboxamide Chemical compound C1N(C(=O)NCCCCC)CCC2=C1SC(NC(N)=N)=N2 YHBVQQYSGAVNFE-UHFFFAOYSA-N 0.000 claims description 2
• ALIKGSQZHJPGOJ-UHFFFAOYSA-N 2-(diaminomethylideneamino)-n-phenyl-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxamide Chemical compound C1CCC=2SC(NC(=N)N)=NC=2C1C(=O)NC1=CC=CC=C1 ALIKGSQZHJPGOJ-UHFFFAOYSA-N 0.000 claims description 2
• QMAOJYKWYMFLDP-UHFFFAOYSA-N 2-(diaminomethylideneamino)-n-phenyl-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxamide Chemical compound C1C=2SC(NC(=N)N)=NC=2CCC1C(=O)NC1=CC=CC=C1 QMAOJYKWYMFLDP-UHFFFAOYSA-N 0.000 claims description 2
• QJHYMDXVSYZIDQ-UHFFFAOYSA-N 2-(diaminomethylideneamino)-n-phenyl-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridine-5-carboxamide Chemical compound C1C=2SC(NC(=N)N)=NC=2CCN1C(=O)NC1=CC=CC=C1 QJHYMDXVSYZIDQ-UHFFFAOYSA-N 0.000 claims description 2
• ZCBZWGQVGHFAOB-UHFFFAOYSA-N 2-(diaminomethylideneamino)-n-propan-2-yl-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridine-5-carbothioamide Chemical compound C1N(C(=S)NC(C)C)CCC2=C1SC(N=C(N)N)=N2 ZCBZWGQVGHFAOB-UHFFFAOYSA-N 0.000 claims description 2
• VMNCXUGRHQUZEF-UHFFFAOYSA-N 2-(diaminomethylideneamino)-n-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxamide Chemical compound CCCNC(=O)C1CCCC2=C1N=C(NC(N)=N)S2 VMNCXUGRHQUZEF-UHFFFAOYSA-N 0.000 claims description 2
• QWHJPAKVYVBKFQ-UHFFFAOYSA-N 2-(diaminomethylideneamino)-n-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxamide Chemical compound C1C(C(=O)NCCC)CCC2=C1SC(NC(N)=N)=N2 QWHJPAKVYVBKFQ-UHFFFAOYSA-N 0.000 claims description 2
• YAJZFNWYKDVSPN-UHFFFAOYSA-N 2-(diaminomethylideneamino)-n-propyl-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridine-5-carbothioamide Chemical compound C1N(C(=S)NCCC)CCC2=C1SC(NC(N)=N)=N2 YAJZFNWYKDVSPN-UHFFFAOYSA-N 0.000 claims description 2
• OLDBFYAXTHRQGT-UHFFFAOYSA-N 2-[4-(2-cyanoethyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]guanidine Chemical compound N#CCCC1CCCC2=C1N=C(NC(=N)N)S2 OLDBFYAXTHRQGT-UHFFFAOYSA-N 0.000 claims description 2
• PGEHXVOYKVRYKK-UHFFFAOYSA-N 2-[4-(morpholine-4-carbonyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]guanidine Chemical compound C1CCC=2SC(NC(=N)N)=NC=2C1C(=O)N1CCOCC1 PGEHXVOYKVRYKK-UHFFFAOYSA-N 0.000 claims description 2
• QBAXFGDLEDRYCD-UHFFFAOYSA-N 2-[4-(piperidine-1-carbonyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]guanidine Chemical compound C1CCC=2SC(NC(=N)N)=NC=2C1C(=O)N1CCCCC1 QBAXFGDLEDRYCD-UHFFFAOYSA-N 0.000 claims description 2
• KUORHFIBNWNBCM-UHFFFAOYSA-N 2-[4-methyl-4-(2-methylpropyl)-6,7-dihydro-5h-1,3-benzothiazol-2-yl]guanidine Chemical compound CC(C)CC1(C)CCCC2=C1N=C(NC(N)=N)S2 KUORHFIBNWNBCM-UHFFFAOYSA-N 0.000 claims description 2
• DGPJUHKVGVAYFQ-UHFFFAOYSA-N 2-[5-(2,2-dimethylpropanoyl)-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-2-yl]guanidine Chemical compound C1N(C(=O)C(C)(C)C)CCC2=C1SC(NC(N)=N)=N2 DGPJUHKVGVAYFQ-UHFFFAOYSA-N 0.000 claims description 2
• GKIINEKRXYIBOE-UHFFFAOYSA-N 2-[5-(2-cyclohexylethyl)-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-2-yl]guanidine Chemical compound C1C=2SC(NC(=N)N)=NC=2CCN1CCC1CCCCC1 GKIINEKRXYIBOE-UHFFFAOYSA-N 0.000 claims description 2
• BPPIBKABLSGTFE-UHFFFAOYSA-N 2-[5-(2-methoxyacetyl)-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-2-yl]guanidine Chemical compound C1N(C(=O)COC)CCC2=C1SC(NC(N)=N)=N2 BPPIBKABLSGTFE-UHFFFAOYSA-N 0.000 claims description 2
• RCNHNMAWLLOAOJ-UHFFFAOYSA-N 2-[5-(2-methylpropanoyl)-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-2-yl]guanidine Chemical compound C1N(C(=O)C(C)C)CCC2=C1SC(NC(N)=N)=N2 RCNHNMAWLLOAOJ-UHFFFAOYSA-N 0.000 claims description 2
• MYUICDHWHUMZEA-UHFFFAOYSA-N 2-[5-(2-phenylacetyl)-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-2-yl]guanidine Chemical compound C1C=2SC(NC(=N)N)=NC=2CCN1C(=O)CC1=CC=CC=C1 MYUICDHWHUMZEA-UHFFFAOYSA-N 0.000 claims description 2
• UVLDXSZZKIUHOW-UHFFFAOYSA-N 2-[5-(2-propylpentanoyl)-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-2-yl]guanidine Chemical compound C1N(C(=O)C(CCC)CCC)CCC2=C1SC(NC(N)=N)=N2 UVLDXSZZKIUHOW-UHFFFAOYSA-N 0.000 claims description 2
• UKUVYTPNVLZSTP-UHFFFAOYSA-N 2-[5-(3-methylbutanoyl)-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-2-yl]guanidine Chemical compound C1N(C(=O)CC(C)C)CCC2=C1SC(NC(N)=N)=N2 UKUVYTPNVLZSTP-UHFFFAOYSA-N 0.000 claims description 2
• BRIXYPSRMAHGQV-UHFFFAOYSA-N 2-[5-(cyclopropanecarbonyl)-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-2-yl]guanidine Chemical compound C1C=2SC(NC(=N)N)=NC=2CCN1C(=O)C1CC1 BRIXYPSRMAHGQV-UHFFFAOYSA-N 0.000 claims description 2
• WOJBUSILFWSVLQ-UHFFFAOYSA-N 2-[5-(cyclopropylmethyl)-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-2-yl]guanidine Chemical compound C1C=2SC(NC(=N)N)=NC=2CCN1CC1CC1 WOJBUSILFWSVLQ-UHFFFAOYSA-N 0.000 claims description 2
• JKMOGNVHEODIIA-UHFFFAOYSA-N 2-[5-[4-(dimethylamino)butanoyl]-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-2-yl]guanidine Chemical compound C1N(C(=O)CCCN(C)C)CCC2=C1SC(NC(N)=N)=N2 JKMOGNVHEODIIA-UHFFFAOYSA-N 0.000 claims description 2
• RYUQUTMSWWQHDN-UHFFFAOYSA-N 2-[6-(1,3-benzodioxol-5-yl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]guanidine Chemical compound C1=C2OCOC2=CC(C2CCC=3N=C(SC=3C2)NC(=N)N)=C1 RYUQUTMSWWQHDN-UHFFFAOYSA-N 0.000 claims description 2
• CZNVBYAATSFUEC-UHFFFAOYSA-N 2-[6-(2-ethylphenyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]guanidine Chemical compound CCC1=CC=CC=C1C1CC(SC(NC(N)=N)=N2)=C2CC1 CZNVBYAATSFUEC-UHFFFAOYSA-N 0.000 claims description 2
• DNVHHWOTOLMWSB-UHFFFAOYSA-N 2-[6-(2-methylbutan-2-yl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]guanidine Chemical compound C1C(C(C)(C)CC)CCC2=C1SC(NC(N)=N)=N2 DNVHHWOTOLMWSB-UHFFFAOYSA-N 0.000 claims description 2
• KKWDSXAYVVPOSC-UHFFFAOYSA-N 2-[6-(2-methylphenyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]guanidine Chemical compound CC1=CC=CC=C1C1CC(SC(NC(N)=N)=N2)=C2CC1 KKWDSXAYVVPOSC-UHFFFAOYSA-N 0.000 claims description 2
• VBWKHBVNGLOMEL-UHFFFAOYSA-N 2-[6-(3,4-dimethoxyphenyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]guanidine Chemical compound C1=C(OC)C(OC)=CC=C1C1CC(SC(NC(N)=N)=N2)=C2CC1 VBWKHBVNGLOMEL-UHFFFAOYSA-N 0.000 claims description 2
• IROVJGFIGHPFLS-UHFFFAOYSA-N 2-[6-(3-fluorophenyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]guanidine Chemical compound C1C=2SC(NC(=N)N)=NC=2CCC1C1=CC=CC(F)=C1 IROVJGFIGHPFLS-UHFFFAOYSA-N 0.000 claims description 2
• DDDUCRJPRWKKKY-UHFFFAOYSA-N 2-[6-(3-methoxyphenyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]guanidine Chemical compound COC1=CC=CC(C2CC=3SC(NC(N)=N)=NC=3CC2)=C1 DDDUCRJPRWKKKY-UHFFFAOYSA-N 0.000 claims description 2
• UXEKPCNXIWZWAG-UHFFFAOYSA-N 2-[6-(3-methylphenyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]guanidine Chemical compound CC1=CC=CC(C2CC=3SC(NC(N)=N)=NC=3CC2)=C1 UXEKPCNXIWZWAG-UHFFFAOYSA-N 0.000 claims description 2
• CJLNCVIOLBBNAW-UHFFFAOYSA-N 2-[6-(4-chlorophenyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]guanidine Chemical compound C1C=2SC(NC(=N)N)=NC=2CCC1C1=CC=C(Cl)C=C1 CJLNCVIOLBBNAW-UHFFFAOYSA-N 0.000 claims description 2
• WILQXUIJHGWVOK-UHFFFAOYSA-N 2-[6-(4-cyanophenyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]guanidine Chemical compound C1C=2SC(NC(=N)N)=NC=2CCC1C1=CC=C(C#N)C=C1 WILQXUIJHGWVOK-UHFFFAOYSA-N 0.000 claims description 2
• IRVMFCFOFBGZBJ-UHFFFAOYSA-N 2-[6-(4-fluorophenyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]guanidine Chemical compound C1C=2SC(NC(=N)N)=NC=2CCC1C1=CC=C(F)C=C1 IRVMFCFOFBGZBJ-UHFFFAOYSA-N 0.000 claims description 2
• BOCJZKCHIVAJRT-UHFFFAOYSA-N 2-[6-(4-methoxyphenyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]guanidine Chemical compound C1=CC(OC)=CC=C1C1CC(SC(NC(N)=N)=N2)=C2CC1 BOCJZKCHIVAJRT-UHFFFAOYSA-N 0.000 claims description 2
• NYPVDISAGXPBQO-UHFFFAOYSA-N 2-[6-(4-methylphenyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]guanidine Chemical compound C1=CC(C)=CC=C1C1CC(SC(NC(N)=N)=N2)=C2CC1 NYPVDISAGXPBQO-UHFFFAOYSA-N 0.000 claims description 2
• UFDPKDBPVLGWBZ-UHFFFAOYSA-N 2-[6-(4-phenylmethoxyphenyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]guanidine Chemical compound C1C=2SC(NC(=N)N)=NC=2CCC1C(C=C1)=CC=C1OCC1=CC=CC=C1 UFDPKDBPVLGWBZ-UHFFFAOYSA-N 0.000 claims description 2
• 125000006325 2-propenyl amino group Chemical group [H]C([H])=C([H])C([H])([H])N([H])* 0.000 claims description 2
• 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims description 2
• 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims description 2
• 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims description 2
• 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims description 2
• 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 2
• QCCKBDNIBZPFCH-UHFFFAOYSA-N 5,6-dihydro-4h-cyclopenta[d][1,3]thiazole Chemical compound N1=CSC2=C1CCC2 QCCKBDNIBZPFCH-UHFFFAOYSA-N 0.000 claims description 2
• HCJNMIIEYLJYGH-UHFFFAOYSA-N 6,7-dihydro-4h-pyrano[4,3-d][1,3]thiazole Chemical compound C1OCCC2=C1SC=N2 HCJNMIIEYLJYGH-UHFFFAOYSA-N 0.000 claims description 2
• LTMDZXQAOVHMKC-UHFFFAOYSA-N CCCCNCC.NC(NC1=NC(C(CCC2)C(O)=O)=C2S1)=N Chemical compound CCCCNCC.NC(NC1=NC(C(CCC2)C(O)=O)=C2S1)=N LTMDZXQAOVHMKC-UHFFFAOYSA-N 0.000 claims description 2
• 206010012335 Dependence Diseases 0.000 claims description 2
• 206010057852 Nicotine dependence Diseases 0.000 claims description 2
• 208000025569 Tobacco Use disease Diseases 0.000 claims description 2
• WFIHKLWVLPBMIQ-UHFFFAOYSA-N [1,3]thiazolo[5,4-b]pyridine Chemical compound C1=CN=C2SC=NC2=C1 WFIHKLWVLPBMIQ-UHFFFAOYSA-N 0.000 claims description 2
• 239000004480 active ingredient Substances 0.000 claims description 2
• 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 claims description 2
• 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 2
• YULUJUFMKYQJDX-UHFFFAOYSA-N butyl 2-(diaminomethylideneamino)-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridine-5-carboxylate Chemical compound C1N(C(=O)OCCCC)CCC2=C1SC(NC(N)=N)=N2 YULUJUFMKYQJDX-UHFFFAOYSA-N 0.000 claims description 2
• 125000006254 cycloalkyl carbonyl group Chemical group 0.000 claims description 2
• 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 2
• PEPAAOWVORGPHG-UHFFFAOYSA-N ethyl 2-(diaminomethylideneamino)-6-phenyl-5,7-dihydro-4h-1,3-benzothiazole-6-carboxylate Chemical compound C1CC=2N=C(NC(N)=N)SC=2CC1(C(=O)OCC)C1=CC=CC=C1 PEPAAOWVORGPHG-UHFFFAOYSA-N 0.000 claims description 2
• NKJVOVNUPGWNBG-UHFFFAOYSA-N ethyl 3-[2-(diaminomethylideneamino)-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-5-yl]propanoate Chemical compound C1N(CCC(=O)OCC)CCC2=C1SC(NC(N)=N)=N2 NKJVOVNUPGWNBG-UHFFFAOYSA-N 0.000 claims description 2
• 125000005226 heteroaryloxycarbonyl group Chemical group 0.000 claims description 2
• 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
• 230000006872 improvement Effects 0.000 claims description 2
• 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 claims description 2
• RZCYPAMUJHRHHV-UHFFFAOYSA-N n-benzyl-2-(diaminomethylideneamino)-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridine-5-carbothioamide Chemical compound C1C=2SC(NC(=N)N)=NC=2CCN1C(=S)NCC1=CC=CC=C1 RZCYPAMUJHRHHV-UHFFFAOYSA-N 0.000 claims description 2
• 125000006257 n-butyloxycarbonyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])OC(*)=O 0.000 claims description 2
• JBJBBZBOTYKFOC-UHFFFAOYSA-N n-tert-butyl-2-(diaminomethylideneamino)-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridine-5-carboxamide Chemical compound C1N(C(=O)NC(C)(C)C)CCC2=C1SC(NC(N)=N)=N2 JBJBBZBOTYKFOC-UHFFFAOYSA-N 0.000 claims description 2
• 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims description 2
• 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 2
• 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 2
• 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 claims description 2
• UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 claims description 2
• 230000008569 process Effects 0.000 claims description 2
• 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 claims description 2
• 229940001470 psychoactive drug Drugs 0.000 claims description 2
• 239000004089 psychotropic agent Substances 0.000 claims description 2
• 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
• NCECOCUSGFFDSY-UHFFFAOYSA-N tert-butyl n-[3-[2-(diaminomethylideneamino)-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-5-yl]-3-oxopropyl]carbamate Chemical compound C1N(C(=O)CCNC(=O)OC(C)(C)C)CCC2=C1SC(NC(N)=N)=N2 NCECOCUSGFFDSY-UHFFFAOYSA-N 0.000 claims description 2
• 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
• 230000029865 regulation of blood pressure Effects 0.000 claims 2
• UYKORIYFERXQTN-UHFFFAOYSA-N 2-(diaminomethylideneamino)-n-(3-methylbutyl)-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxamide Chemical compound CC(C)CCNC(=O)C1CCCC2=C1N=C(NC(N)=N)S2 UYKORIYFERXQTN-UHFFFAOYSA-N 0.000 claims 1
• POANLTXZHXLSIR-UHFFFAOYSA-N 2-(diaminomethylideneamino)-n-methyl-n-(2-phenylethyl)-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxamide Chemical compound C1CCC=2SC(N=C(N)N)=NC=2C1C(=O)N(C)CCC1=CC=CC=C1 POANLTXZHXLSIR-UHFFFAOYSA-N 0.000 claims 1
• 229940122109 Neuropeptide FF receptor antagonist Drugs 0.000 claims 1
• UMKHUSRDQFQHAK-RNJMTYCLSA-N RF9 Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)C12CC3CC(CC(C3)C1)C2)CCCNC(=N)N)C(N)=O)C1=CC=CC=C1 UMKHUSRDQFQHAK-RNJMTYCLSA-N 0.000 claims 1
• 125000002785 azepinyl group Chemical group 0.000 claims 1
• 125000005518 carboxamido group Chemical group 0.000 claims 1
• OYDVACUZLCNVEJ-UHFFFAOYSA-N n-[[2-(diaminomethylideneamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl]methyl]acetamide Chemical compound C1C(CNC(=O)C)CCC2=C1SC(NC(N)=N)=N2 OYDVACUZLCNVEJ-UHFFFAOYSA-N 0.000 claims 1
• 239000000126 substance Substances 0.000 abstract description 18
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 66
• 239000000047 product Substances 0.000 description 42
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 36
• 239000007858 starting material Substances 0.000 description 31
• 238000012512 characterization method Methods 0.000 description 28
• 239000000243 solution Substances 0.000 description 28
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 27
• 239000012043 crude product Substances 0.000 description 27
• 239000002243 precursor Substances 0.000 description 27
• 102400001095 Neuropeptide FF Human genes 0.000 description 26
• 230000015572 biosynthetic process Effects 0.000 description 26
• 108010055752 phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide Proteins 0.000 description 26
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 24
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 24
• 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 24
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
• 239000012074 organic phase Substances 0.000 description 21
• 229910052938 sodium sulfate Inorganic materials 0.000 description 21
• 235000011152 sodium sulphate Nutrition 0.000 description 21
• DWDUCMMIILBMMZ-UHFFFAOYSA-N 2-bromo-4-propan-2-ylcyclohexan-1-one Chemical compound CC(C)C1CCC(=O)C(Br)C1 DWDUCMMIILBMMZ-UHFFFAOYSA-N 0.000 description 20
• 230000031709 bromination Effects 0.000 description 19
• 238000005893 bromination reaction Methods 0.000 description 19
• 239000000203 mixture Substances 0.000 description 19
• 239000002904 solvent Substances 0.000 description 19
• BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 17
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
• 102100029049 Neuropeptide FF receptor 1 Human genes 0.000 description 15
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
• 238000003756 stirring Methods 0.000 description 15
• 101000634561 Homo sapiens Neuropeptide FF receptor 2 Proteins 0.000 description 14
• 102100029050 Neuropeptide FF receptor 2 Human genes 0.000 description 14
• 125000003545 alkoxy group Chemical group 0.000 description 14
• 239000011541 reaction mixture Substances 0.000 description 14
• 101150056943 Npffr1 gene Proteins 0.000 description 13
• 238000006243 chemical reaction Methods 0.000 description 13
• 239000003153 chemical reaction reagent Substances 0.000 description 13
• 108090000765 processed proteins & peptides Proteins 0.000 description 13
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 12
• JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 12
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 12
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
• 125000000623 heterocyclic group Chemical group 0.000 description 12
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 12
• YWGVBWSGYICKHI-UHFFFAOYSA-N 2-tert-butyl-6-chlorocyclohexan-1-one Chemical compound CC(C)(C)C1CCCC(Cl)C1=O YWGVBWSGYICKHI-UHFFFAOYSA-N 0.000 description 11
• 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 11
• 229920006395 saturated elastomer Polymers 0.000 description 11
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 11
• IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 10
• 125000004448 alkyl carbonyl group Chemical group 0.000 description 10
• 239000007864 aqueous solution Substances 0.000 description 10
• 238000001704 evaporation Methods 0.000 description 10
• 125000004183 alkoxy alkyl group Chemical group 0.000 description 9
• 239000002585 base Substances 0.000 description 9
• 238000005660 chlorination reaction Methods 0.000 description 9
• 229910052757 nitrogen Inorganic materials 0.000 description 9
• 102000004196 processed proteins & peptides Human genes 0.000 description 9
• 239000000725 suspension Substances 0.000 description 9
• 239000003643 water by type Substances 0.000 description 9
• HWYCFZUSOBOBIN-AQJXLSMYSA-N (2s)-2-[[(2s)-1-[(2s)-5-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-n-[(2s)-1-[[(2s)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminome Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)C1=CC=CC=C1 HWYCFZUSOBOBIN-AQJXLSMYSA-N 0.000 description 8
• XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 8
• 241000700159 Rattus Species 0.000 description 8
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
• 125000004644 alkyl sulfinyl group Chemical group 0.000 description 8
• 125000004414 alkyl thio group Chemical group 0.000 description 8
• 230000027455 binding Effects 0.000 description 8
• 230000008020 evaporation Effects 0.000 description 8
• 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 8
• 229910052736 halogen Inorganic materials 0.000 description 8
• 150000002367 halogens Chemical class 0.000 description 8
• 125000004435 hydrogen atom Chemical class [H]* 0.000 description 8
• 229960005181 morphine Drugs 0.000 description 8
• 235000011121 sodium hydroxide Nutrition 0.000 description 8
• RUIDGPOZILPJAW-UHFFFAOYSA-N 2-(4,5,6,7-tetrahydro-[1,3]thiazolo[5,4-c]pyridin-2-yl)guanidine Chemical compound C1CNCC2=C1N=C(NC(=N)N)S2 RUIDGPOZILPJAW-UHFFFAOYSA-N 0.000 description 7
• 125000005196 alkyl carbonyloxy group Chemical group 0.000 description 7
• 125000004687 alkyl sulfinyl alkyl group Chemical group 0.000 description 7
• 125000004688 alkyl sulfonyl alkyl group Chemical group 0.000 description 7
• 125000006350 alkyl thio alkyl group Chemical group 0.000 description 7
• 125000005530 alkylenedioxy group Chemical group 0.000 description 7
• 125000004103 aminoalkyl group Chemical group 0.000 description 7
• 125000005097 aminocarbonylalkyl group Chemical group 0.000 description 7
• 125000005018 aryl alkenyl group Chemical group 0.000 description 7
• 125000002102 aryl alkyloxo group Chemical group 0.000 description 7
• 125000004104 aryloxy group Chemical group 0.000 description 7
• 125000004181 carboxyalkyl group Chemical group 0.000 description 7
• 210000003169 central nervous system Anatomy 0.000 description 7
• 230000008878 coupling Effects 0.000 description 7
• 238000010168 coupling process Methods 0.000 description 7
• 238000005859 coupling reaction Methods 0.000 description 7
• 238000001035 drying Methods 0.000 description 7
• 125000004967 formylalkyl group Chemical group 0.000 description 7
• 125000004438 haloalkoxy group Chemical group 0.000 description 7
• 125000001188 haloalkyl group Chemical group 0.000 description 7
• 125000002768 hydroxyalkyl group Chemical group 0.000 description 7
• 125000006239 protecting group Chemical group 0.000 description 7
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
• NHOGKBUDALSELW-UHFFFAOYSA-N 2-(4,5,6,7-tetrahydro-[1,3]thiazolo[5,4-c]pyridin-2-yl)guanidine;dihydrochloride Chemical compound Cl.Cl.C1CNCC2=C1N=C(NC(=N)N)S2 NHOGKBUDALSELW-UHFFFAOYSA-N 0.000 description 6
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 6
• QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 6
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
• 238000005481 NMR spectroscopy Methods 0.000 description 6
• 125000005093 alkyl carbonyl alkyl group Chemical group 0.000 description 6
• 235000019270 ammonium chloride Nutrition 0.000 description 6
• 230000036592 analgesia Effects 0.000 description 6
• 235000019253 formic acid Nutrition 0.000 description 6
• KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 6
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 6
• 125000004433 nitrogen atom Chemical group N* 0.000 description 6
• 229940005483 opioid analgesics Drugs 0.000 description 6
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 6
• 239000000741 silica gel Substances 0.000 description 6
• 229910002027 silica gel Inorganic materials 0.000 description 6
• 229910000029 sodium carbonate Inorganic materials 0.000 description 6
• 238000012360 testing method Methods 0.000 description 6
• 125000003396 thiol group Chemical class [H]S* 0.000 description 6
• KNSPBSQWRKKAPI-UHFFFAOYSA-N 2,2-dimethylcyclohexan-1-one Chemical compound CC1(C)CCCCC1=O KNSPBSQWRKKAPI-UHFFFAOYSA-N 0.000 description 5
• LFSAPCRASZRSKS-UHFFFAOYSA-N 2-methylcyclohexan-1-one Chemical compound CC1CCCCC1=O LFSAPCRASZRSKS-UHFFFAOYSA-N 0.000 description 5
• 150000001412 amines Chemical class 0.000 description 5
• 230000000202 analgesic effect Effects 0.000 description 5
• 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 5
• 125000005135 aryl sulfinyl group Chemical group 0.000 description 5
• 125000005110 aryl thio group Chemical group 0.000 description 5
• 239000000872 buffer Substances 0.000 description 5
• 239000002552 dosage form Substances 0.000 description 5
• 230000000694 effects Effects 0.000 description 5
• 229910052760 oxygen Inorganic materials 0.000 description 5
• 239000001301 oxygen Substances 0.000 description 5
• PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 4
• PXQMSTLNSHMSJB-UHFFFAOYSA-N 4,4-dimethylcyclohexan-1-one Chemical compound CC1(C)CCC(=O)CC1 PXQMSTLNSHMSJB-UHFFFAOYSA-N 0.000 description 4
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
• XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 101710151321 Melanostatin Proteins 0.000 description 4
• MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
• 102400001090 Neuropeptide AF Human genes 0.000 description 4
• 102400000064 Neuropeptide Y Human genes 0.000 description 4
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
• 230000001154 acute effect Effects 0.000 description 4
• 229910052784 alkaline earth metal Inorganic materials 0.000 description 4
• 229910052786 argon Inorganic materials 0.000 description 4
• 125000005164 aryl thioalkyl group Chemical group 0.000 description 4
• 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 4
• 210000004556 brain Anatomy 0.000 description 4
• 238000004587 chromatography analysis Methods 0.000 description 4
• 238000000605 extraction Methods 0.000 description 4
• 150000002430 hydrocarbons Chemical group 0.000 description 4
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 4
• URPYMXQQVHTUDU-OFGSCBOVSA-N nucleopeptide y Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 URPYMXQQVHTUDU-OFGSCBOVSA-N 0.000 description 4
• 239000012071 phase Substances 0.000 description 4
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
• 238000000746 purification Methods 0.000 description 4
• 210000000278 spinal cord Anatomy 0.000 description 4
• ISUXBNXLVOPNBA-UHFFFAOYSA-N spiro[5.5]undecan-5-one Chemical compound O=C1CCCCC11CCCCC1 ISUXBNXLVOPNBA-UHFFFAOYSA-N 0.000 description 4
• 238000003786 synthesis reaction Methods 0.000 description 4
• NOLMGELTBIIGOL-UHFFFAOYSA-N 1,4-dioxaspiro[4.5]dec-7-en-8-yl trifluoromethanesulfonate Chemical compound C1CC(OS(=O)(=O)C(F)(F)F)=CCC21OCCO2 NOLMGELTBIIGOL-UHFFFAOYSA-N 0.000 description 3
• HGWZSFXXGQVVAQ-UHFFFAOYSA-N 1-benzylazepan-3-one Chemical compound C1C(=O)CCCCN1CC1=CC=CC=C1 HGWZSFXXGQVVAQ-UHFFFAOYSA-N 0.000 description 3
• AGXWLXXFBICEON-UHFFFAOYSA-N 2-tert-butyl-4-phenylcyclohexan-1-one Chemical compound C1CC(=O)C(C(C)(C)C)CC1C1=CC=CC=C1 AGXWLXXFBICEON-UHFFFAOYSA-N 0.000 description 3
• ORIINXCHZXECLA-UHFFFAOYSA-N 3-butylcyclohexan-1-one Chemical compound CCCCC1CCCC(=O)C1 ORIINXCHZXECLA-UHFFFAOYSA-N 0.000 description 3
• QJPHZZUBQAASNR-UHFFFAOYSA-N 4,4-diphenylcyclohexan-1-one Chemical compound C1CC(=O)CCC1(C=1C=CC=CC=1)C1=CC=CC=C1 QJPHZZUBQAASNR-UHFFFAOYSA-N 0.000 description 3
• KSQIGHIYGAPXCW-UHFFFAOYSA-N 4-(4-fluorophenyl)cyclohexan-1-one Chemical compound C1=CC(F)=CC=C1C1CCC(=O)CC1 KSQIGHIYGAPXCW-UHFFFAOYSA-N 0.000 description 3
• OKRGFVFQVDARGW-UHFFFAOYSA-N 5-[benzyl-(2-ethoxy-2-oxoethyl)amino]pentanoic acid Chemical compound OC(=O)CCCCN(CC(=O)OCC)CC1=CC=CC=C1 OKRGFVFQVDARGW-UHFFFAOYSA-N 0.000 description 3
• PZFNLQSLQXNSIN-UHFFFAOYSA-N 8-(4-fluorophenyl)-1,4-dioxaspiro[4.5]decane Chemical compound C1=CC(F)=CC=C1C1CCC2(OCCO2)CC1 PZFNLQSLQXNSIN-UHFFFAOYSA-N 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
• VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
• BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 3
• 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 3
• 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 3
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
• SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
• 101800001049 Neuropeptide AF Proteins 0.000 description 3
• 101800000150 Neuropeptide AF-like Proteins 0.000 description 3
• MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
• KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
• OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
• 239000007983 Tris buffer Substances 0.000 description 3
• 230000029936 alkylation Effects 0.000 description 3
• 238000005804 alkylation reaction Methods 0.000 description 3
• 239000005557 antagonist Substances 0.000 description 3
• 230000033228 biological regulation Effects 0.000 description 3
• 230000036772 blood pressure Effects 0.000 description 3
• 150000001721 carbon Chemical group 0.000 description 3
• 210000004027 cell Anatomy 0.000 description 3
• IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 238000001816 cooling Methods 0.000 description 3
• GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 3
• 238000011161 development Methods 0.000 description 3
• UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
• 125000004185 ester group Chemical group 0.000 description 3
• 125000004494 ethyl ester group Chemical group 0.000 description 3
• 239000005457 ice water Substances 0.000 description 3
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
• 239000007924 injection Substances 0.000 description 3
• 238000002347 injection Methods 0.000 description 3
• 230000005923 long-lasting effect Effects 0.000 description 3
• 239000012528 membrane Substances 0.000 description 3
• OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 3
• DYSIROANKWMSGC-KWFINLGMSA-N npaf Chemical compound C([C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](C)N)CC(C)C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)C1=CC=CC=C1 DYSIROANKWMSGC-KWFINLGMSA-N 0.000 description 3
• 239000002245 particle Substances 0.000 description 3
• 230000000144 pharmacologic effect Effects 0.000 description 3
• 125000003367 polycyclic group Chemical group 0.000 description 3
• 108090000623 proteins and genes Proteins 0.000 description 3
• 102000005962 receptors Human genes 0.000 description 3
• 108020003175 receptors Proteins 0.000 description 3
• 229910052708 sodium Inorganic materials 0.000 description 3
• 239000011734 sodium Substances 0.000 description 3
• FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
• 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 3
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
• DKDWYSSSCHORRJ-UHFFFAOYSA-N 1-benzyl-4-bromoazepan-3-one Chemical compound C1C(=O)C(Br)CCCN1CC1=CC=CC=C1 DKDWYSSSCHORRJ-UHFFFAOYSA-N 0.000 description 2
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
• HWWMXGWPAOOQOE-UHFFFAOYSA-N 2-ethyl-2-methylcyclohexan-1-one Chemical compound CCC1(C)CCCCC1=O HWWMXGWPAOOQOE-UHFFFAOYSA-N 0.000 description 2
• MQYJJCJOKJTXHT-UHFFFAOYSA-N 2-methyl-2-(2-methylpropyl)cyclohexan-1-one Chemical compound CC(C)CC1(C)CCCCC1=O MQYJJCJOKJTXHT-UHFFFAOYSA-N 0.000 description 2
• XPDCYLHNNYXXFF-UHFFFAOYSA-N 2-methyl-2-propylcyclohexan-1-one Chemical compound CCCC1(C)CCCCC1=O XPDCYLHNNYXXFF-UHFFFAOYSA-N 0.000 description 2
• VMZYKKVDRMKAFB-UHFFFAOYSA-N 2-phenylspiro[5.5]undecan-5-one Chemical compound O=C1CCC(C=2C=CC=CC=2)CC11CCCCC1 VMZYKKVDRMKAFB-UHFFFAOYSA-N 0.000 description 2
• CGMLOUSLYNMMCC-UHFFFAOYSA-N 3,3-dimethyl-4-phenylcyclohexan-1-one Chemical compound CC1(C)CC(=O)CCC1C1=CC=CC=C1 CGMLOUSLYNMMCC-UHFFFAOYSA-N 0.000 description 2
• BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
• VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
• GEPLRUHKORZDGH-UHFFFAOYSA-N 4-bromospiro[5.5]undecan-5-one Chemical compound O=C1C(Br)CCCC11CCCCC1 GEPLRUHKORZDGH-UHFFFAOYSA-N 0.000 description 2
• DJECMZKAFHJFMI-UHFFFAOYSA-N 8-(4-fluorophenyl)-1,4-dioxaspiro[4.5]dec-7-ene Chemical compound C1=CC(F)=CC=C1C(CC1)=CCC21OCCO2 DJECMZKAFHJFMI-UHFFFAOYSA-N 0.000 description 2
• 239000004475 Arginine Substances 0.000 description 2
• 241000283690 Bos taurus Species 0.000 description 2
• WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
• 208000000094 Chronic Pain Diseases 0.000 description 2
• AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
• 101000634565 Homo sapiens Neuropeptide FF receptor 1 Proteins 0.000 description 2
• 101001108239 Homo sapiens Pro-FMRFamide-related neuropeptide VF Proteins 0.000 description 2
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
• 241001465754 Metazoa Species 0.000 description 2
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
• YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
• LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
• PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
• 0 NC(Nc1nc(CCC*CC2)c2[s]1)=N Chemical compound NC(Nc1nc(CCC*CC2)c2[s]1)=N 0.000 description 2
• 102400001094 Neuropeptide SF Human genes 0.000 description 2
• 101800001355 Neuropeptide SF Proteins 0.000 description 2
• 108090000189 Neuropeptides Proteins 0.000 description 2
• 208000026251 Opioid-Related disease Diseases 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
• 102100021876 Pro-FMRFamide-related neuropeptide VF Human genes 0.000 description 2
• LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
• DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
• HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
• TXBIJPMTUNMCHF-UHFFFAOYSA-N [Mg]CBr Chemical compound [Mg]CBr TXBIJPMTUNMCHF-UHFFFAOYSA-N 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 239000003513 alkali Substances 0.000 description 2
• 150000001350 alkyl halides Chemical class 0.000 description 2
• 150000001413 amino acids Chemical group 0.000 description 2
• 125000003277 amino group Chemical group 0.000 description 2
• 238000004458 analytical method Methods 0.000 description 2
• 239000008346 aqueous phase Substances 0.000 description 2
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
• IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
• WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
• 125000002619 bicyclic group Chemical group 0.000 description 2
• 239000012148 binding buffer Substances 0.000 description 2
• GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
• 229910052794 bromium Inorganic materials 0.000 description 2
• 244000309464 bull Species 0.000 description 2
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
• 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
• 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
• 238000004113 cell culture Methods 0.000 description 2
• MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
• 230000001684 chronic effect Effects 0.000 description 2
• 238000004440 column chromatography Methods 0.000 description 2
• 125000004122 cyclic group Chemical group 0.000 description 2
• JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
• XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
• ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
• VKCMWLOBUILIOQ-UHFFFAOYSA-N ethyl 3-bromo-2-oxocyclohexane-1-carboxylate Chemical compound CCOC(=O)C1CCCC(Br)C1=O VKCMWLOBUILIOQ-UHFFFAOYSA-N 0.000 description 2
• 238000001914 filtration Methods 0.000 description 2
• 239000012458 free base Substances 0.000 description 2
• 125000004449 heterocyclylalkenyl group Chemical group 0.000 description 2
• 125000005844 heterocyclyloxy group Chemical group 0.000 description 2
• 238000004128 high performance liquid chromatography Methods 0.000 description 2
• 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 2
• 150000007529 inorganic bases Chemical class 0.000 description 2
• 239000013067 intermediate product Substances 0.000 description 2
• ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
• 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
• 239000007788 liquid Substances 0.000 description 2
• 238000005259 measurement Methods 0.000 description 2
• 125000002950 monocyclic group Chemical group 0.000 description 2
• 102000051367 mu Opioid Receptors Human genes 0.000 description 2
• 108010060265 neuropeptide VF Proteins 0.000 description 2
• 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
• 230000009871 nonspecific binding Effects 0.000 description 2
• 201000005040 opiate dependence Diseases 0.000 description 2
• 150000007530 organic bases Chemical class 0.000 description 2
• 239000003960 organic solvent Substances 0.000 description 2
• KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
• NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
• YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
• 229910052700 potassium Inorganic materials 0.000 description 2
• 239000011591 potassium Substances 0.000 description 2
• 229910000027 potassium carbonate Inorganic materials 0.000 description 2
• LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
• 238000001556 precipitation Methods 0.000 description 2
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
• 238000003757 reverse transcription PCR Methods 0.000 description 2
• 238000004007 reversed phase HPLC Methods 0.000 description 2
• YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
• GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
• 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 2
• 208000024891 symptom Diseases 0.000 description 2
• 125000004149 thio group Chemical group *S* 0.000 description 2
• 150000003585 thioureas Chemical class 0.000 description 2
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
• 230000000472 traumatic effect Effects 0.000 description 2
• LRYIGXAAWHNNOA-UHFFFAOYSA-N trimethyl-(3-methylcyclohexyl)oxysilane Chemical compound CC1CCCC(O[Si](C)(C)C)C1 LRYIGXAAWHNNOA-UHFFFAOYSA-N 0.000 description 2
• GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
• 108020001612 μ-opioid receptors Proteins 0.000 description 2
• QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
• PHBVXHIVWULVNF-UHFFFAOYSA-N (4-fluorophenoxy)boronic acid Chemical compound OB(O)OC1=CC=C(F)C=C1 PHBVXHIVWULVNF-UHFFFAOYSA-N 0.000 description 1
• DIOHEXPTUTVCNX-UHFFFAOYSA-N 1,1,1-trifluoro-n-phenyl-n-(trifluoromethylsulfonyl)methanesulfonamide Chemical compound FC(F)(F)S(=O)(=O)N(S(=O)(=O)C(F)(F)F)C1=CC=CC=C1 DIOHEXPTUTVCNX-UHFFFAOYSA-N 0.000 description 1
• FIARMZDBEGVMLV-UHFFFAOYSA-N 1,1,2,2,2-pentafluoroethanolate Chemical group [O-]C(F)(F)C(F)(F)F FIARMZDBEGVMLV-UHFFFAOYSA-N 0.000 description 1
• 125000005988 1,1-dioxo-thiomorpholinyl group Chemical group 0.000 description 1
• RDJUHLUBPADHNP-UHFFFAOYSA-N 1,2,3,5-tetrahydroxybenzene Chemical compound OC1=CC(O)=C(O)C(O)=C1 RDJUHLUBPADHNP-UHFFFAOYSA-N 0.000 description 1
• BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 1
• GZGPRZYZKBQPBQ-UHFFFAOYSA-N 1,4-dioxaspiro[4.5]decane Chemical compound O1CCOC11CCCCC1 GZGPRZYZKBQPBQ-UHFFFAOYSA-N 0.000 description 1
• MNDIARAMWBIKFW-UHFFFAOYSA-N 1-bromohexane Chemical compound CCCCCCBr MNDIARAMWBIKFW-UHFFFAOYSA-N 0.000 description 1
• 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 1
• BTUGGGLMQBJCBN-UHFFFAOYSA-N 1-iodo-2-methylpropane Chemical compound CC(C)CI BTUGGGLMQBJCBN-UHFFFAOYSA-N 0.000 description 1
• VRVUKQWNRPNACD-UHFFFAOYSA-N 1-isocyanatopentane Chemical compound CCCCCN=C=O VRVUKQWNRPNACD-UHFFFAOYSA-N 0.000 description 1
• 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
• ARDJZBUWZOQXCO-UHFFFAOYSA-N 2-(2-oxocyclohexyl)ethyl acetate Chemical compound CC(=O)OCCC1CCCCC1=O ARDJZBUWZOQXCO-UHFFFAOYSA-N 0.000 description 1
• GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 1
• UKBKRAWBZJVRER-UHFFFAOYSA-N 2-(diaminomethylideneamino)-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxylic acid formic acid Chemical compound N(C(=N)N)C=1SC2=C(N1)C(CCC2)C(=O)O.C(=O)O UKBKRAWBZJVRER-UHFFFAOYSA-N 0.000 description 1
• GRFKGPRMVDHIBO-UHFFFAOYSA-N 2-(diaminomethylideneamino)-n-(3-methylbutyl)-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxamide;formic acid Chemical compound OC=O.CC(C)CCNC(=O)C1CCCC2=C1N=C(NC(N)=N)S2 GRFKGPRMVDHIBO-UHFFFAOYSA-N 0.000 description 1
• NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
• 125000000979 2-amino-2-oxoethyl group Chemical group [H]C([*])([H])C(=O)N([H])[H] 0.000 description 1
• 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
• BCNPAUNXYDNKOU-UHFFFAOYSA-N 2-benzyl-6-chlorocyclohexan-1-one Chemical compound O=C1C(Cl)CCCC1CC1=CC=CC=C1 BCNPAUNXYDNKOU-UHFFFAOYSA-N 0.000 description 1
• CUYLPYBYCYQGCE-UHFFFAOYSA-N 2-benzylcyclohexan-1-one Chemical compound O=C1CCCCC1CC1=CC=CC=C1 CUYLPYBYCYQGCE-UHFFFAOYSA-N 0.000 description 1
• JUAKSRQOOTYMMW-UHFFFAOYSA-N 2-bromo-3-methylcyclohexan-1-one Chemical compound CC1CCCC(=O)C1Br JUAKSRQOOTYMMW-UHFFFAOYSA-N 0.000 description 1
• RDUXIRQZBLFPOW-UHFFFAOYSA-N 2-bromo-4,4-dimethylcyclohexan-1-one Chemical compound CC1(C)CCC(=O)C(Br)C1 RDUXIRQZBLFPOW-UHFFFAOYSA-N 0.000 description 1
• IPGQCGUVCWKFFK-UHFFFAOYSA-N 2-bromo-4,4-diphenylcyclohexan-1-one Chemical compound C1CC(=O)C(Br)CC1(C=1C=CC=CC=1)C1=CC=CC=C1 IPGQCGUVCWKFFK-UHFFFAOYSA-N 0.000 description 1
• RIGJPLUFCMBWDR-UHFFFAOYSA-N 2-bromo-5,5-dimethyl-4-phenylcyclohexan-1-one Chemical compound CC1(C)CC(=O)C(Br)CC1C1=CC=CC=C1 RIGJPLUFCMBWDR-UHFFFAOYSA-N 0.000 description 1
• XGYKCZMGYRAOPT-UHFFFAOYSA-N 2-bromo-5,5-dimethylcyclohexan-1-one Chemical compound CC1(C)CCC(Br)C(=O)C1 XGYKCZMGYRAOPT-UHFFFAOYSA-N 0.000 description 1
• DIEBEDGOEZHZSB-UHFFFAOYSA-N 2-bromo-5-butylcyclohexan-1-one Chemical compound CCCCC1CCC(Br)C(=O)C1 DIEBEDGOEZHZSB-UHFFFAOYSA-N 0.000 description 1
• IPYJGSOJTCUXNW-UHFFFAOYSA-N 2-bromo-5-ethyl-5-methylcyclohexan-1-one Chemical compound CCC1(C)CCC(Br)C(=O)C1 IPYJGSOJTCUXNW-UHFFFAOYSA-N 0.000 description 1
• RJXGPKUQWMEERF-UHFFFAOYSA-N 2-bromo-5-methyl-5-phenylcyclohexan-1-one Chemical compound C=1C=CC=CC=1C1(C)CCC(Br)C(=O)C1 RJXGPKUQWMEERF-UHFFFAOYSA-N 0.000 description 1
• CERICSCKCBQTGV-UHFFFAOYSA-N 2-bromo-6-phenylcycloheptan-1-one Chemical compound C1C(=O)C(Br)CCCC1C1=CC=CC=C1 CERICSCKCBQTGV-UHFFFAOYSA-N 0.000 description 1
• WKUWKLBEUOLWEA-UHFFFAOYSA-N 2-butan-2-yl-6-chlorocyclohexan-1-one Chemical compound CCC(C)C1CCCC(Cl)C1=O WKUWKLBEUOLWEA-UHFFFAOYSA-N 0.000 description 1
• RQXTZKGDMNIWJF-UHFFFAOYSA-N 2-butan-2-ylcyclohexan-1-one Chemical compound CCC(C)C1CCCCC1=O RQXTZKGDMNIWJF-UHFFFAOYSA-N 0.000 description 1
• 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 description 1
• HAIHXZYHTQDIGZ-UHFFFAOYSA-N 2-chloro-6-methylcyclohexan-1-one Chemical compound CC1CCCC(Cl)C1=O HAIHXZYHTQDIGZ-UHFFFAOYSA-N 0.000 description 1
• QCXZSWMQNZFHIB-UHFFFAOYSA-N 2-chloro-6-phenylcyclohexan-1-one Chemical compound O=C1C(Cl)CCCC1C1=CC=CC=C1 QCXZSWMQNZFHIB-UHFFFAOYSA-N 0.000 description 1
• JCJODSMQBXMELN-UHFFFAOYSA-N 2-ethyl-5-phenyl-1,2-oxazol-2-ium Chemical class O1[N+](CC)=CC=C1C1=CC=CC=C1 JCJODSMQBXMELN-UHFFFAOYSA-N 0.000 description 1
• 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
• 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
• MGOLNIXAPIAKFM-UHFFFAOYSA-N 2-isocyanato-2-methylpropane Chemical compound CC(C)(C)N=C=O MGOLNIXAPIAKFM-UHFFFAOYSA-N 0.000 description 1
• 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
• 125000006022 2-methyl-2-propenyl group Chemical group 0.000 description 1
• YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
• DRLVMOAWNVOSPE-UHFFFAOYSA-N 2-phenylcyclohexan-1-one Chemical compound O=C1CCCCC1C1=CC=CC=C1 DRLVMOAWNVOSPE-UHFFFAOYSA-N 0.000 description 1
• 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
• UPGHEUSRLZSXAE-UHFFFAOYSA-N 2-prop-2-enylcyclohexan-1-one Chemical compound C=CCC1CCCCC1=O UPGHEUSRLZSXAE-UHFFFAOYSA-N 0.000 description 1
• SDJUYPUXVFDUFF-UHFFFAOYSA-N 2-propan-2-ylcyclohexan-1-one Chemical compound CC(C)C1CCCCC1=O SDJUYPUXVFDUFF-UHFFFAOYSA-N 0.000 description 1
• 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
• SLVUSOBENQLINV-UHFFFAOYSA-N 2-tert-butyl-6-chloro-4-phenylcyclohexan-1-one Chemical compound C1C(Cl)C(=O)C(C(C)(C)C)CC1C1=CC=CC=C1 SLVUSOBENQLINV-UHFFFAOYSA-N 0.000 description 1
• ZRYDPLOWJSFQAE-UHFFFAOYSA-N 2-tert-butylcyclohexan-1-one Chemical compound CC(C)(C)C1CCCCC1=O ZRYDPLOWJSFQAE-UHFFFAOYSA-N 0.000 description 1
• SXNMUZQWTWBSBL-UHFFFAOYSA-N 2h-cyclohepta[d][1,3]thiazole Chemical class C1=CC=CC2=NCSC2=C1 SXNMUZQWTWBSBL-UHFFFAOYSA-N 0.000 description 1
• DVNAEKRGMBNCFF-UHFFFAOYSA-N 2h-cyclopenta[d][1,3]thiazole Chemical class C1=CC2=NCSC2=C1 DVNAEKRGMBNCFF-UHFFFAOYSA-N 0.000 description 1
• MSMLIBSQLHMWMS-UHFFFAOYSA-N 2h-pyrano[2,3-d][1,3]thiazole Chemical class C1=COC2=NCSC2=C1 MSMLIBSQLHMWMS-UHFFFAOYSA-N 0.000 description 1
• NTIGNJOEVBTPJJ-UHFFFAOYSA-N 3,3-dibromopentane Chemical compound CCC(Br)(Br)CC NTIGNJOEVBTPJJ-UHFFFAOYSA-N 0.000 description 1
• ZVJQBBYAVPAFLX-UHFFFAOYSA-N 3,3-dimethylcyclohexan-1-one Chemical compound CC1(C)CCCC(=O)C1 ZVJQBBYAVPAFLX-UHFFFAOYSA-N 0.000 description 1
• SPTVCXKSSRBTMN-UHFFFAOYSA-N 3-(2-oxocyclohexyl)propanenitrile Chemical compound O=C1CCCCC1CCC#N SPTVCXKSSRBTMN-UHFFFAOYSA-N 0.000 description 1
• GKHLYBAJBIPWLN-UHFFFAOYSA-N 3-(3-chloro-2-oxocyclohexyl)propanenitrile Chemical compound ClC1CCCC(CCC#N)C1=O GKHLYBAJBIPWLN-UHFFFAOYSA-N 0.000 description 1
• FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
• CTVZFWLJZYXVBA-UHFFFAOYSA-N 3-bromo-4-oxo-1-phenylcyclohexane-1-carbonitrile Chemical compound C1CC(=O)C(Br)CC1(C#N)C1=CC=CC=C1 CTVZFWLJZYXVBA-UHFFFAOYSA-N 0.000 description 1
• QAHHVIYXYRBQPU-UHFFFAOYSA-N 3-bromo-4-oxocyclohexane-1-carboxylic acid Chemical compound OC(=O)C1CCC(=O)C(Br)C1 QAHHVIYXYRBQPU-UHFFFAOYSA-N 0.000 description 1
• 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
• 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
• HPFWICIZVJFFNM-UHFFFAOYSA-N 3-ethyl-3-methylcyclohexan-1-one Chemical compound CCC1(C)CCCC(=O)C1 HPFWICIZVJFFNM-UHFFFAOYSA-N 0.000 description 1
• QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
• HOIXVJDJSJNGFM-UHFFFAOYSA-N 3-methyl-3-phenylcyclohexan-1-one Chemical compound C=1C=CC=CC=1C1(C)CCCC(=O)C1 HOIXVJDJSJNGFM-UHFFFAOYSA-N 0.000 description 1
• JLDCLDZGNYDRKX-UHFFFAOYSA-N 3-phenylcycloheptan-1-one Chemical compound C1C(=O)CCCCC1C1=CC=CC=C1 JLDCLDZGNYDRKX-UHFFFAOYSA-N 0.000 description 1
• 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• RMFVVPBBEDMZQI-UHFFFAOYSA-N 4,5,6,7-tetrahydro-1,3-benzothiazole Chemical compound C1CCCC2=C1N=CS2 RMFVVPBBEDMZQI-UHFFFAOYSA-N 0.000 description 1
• ZTNXPEAVOZZOGK-UHFFFAOYSA-N 4-(1,3-benzodioxol-5-yl)cyclohexan-1-one Chemical compound C1CC(=O)CCC1C1=CC=C(OCO2)C2=C1 ZTNXPEAVOZZOGK-UHFFFAOYSA-N 0.000 description 1
• GBBVNWWMXGGWBZ-UHFFFAOYSA-N 4-(2-ethylphenyl)cyclohexan-1-one Chemical compound CCC1=CC=CC=C1C1CCC(=O)CC1 GBBVNWWMXGGWBZ-UHFFFAOYSA-N 0.000 description 1
• DXLIAYMTYKXAKB-UHFFFAOYSA-N 4-(2-methylphenyl)cyclohexan-1-one Chemical compound CC1=CC=CC=C1C1CCC(=O)CC1 DXLIAYMTYKXAKB-UHFFFAOYSA-N 0.000 description 1
• ZFNPIMGGFINZOM-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)cyclohexan-1-one Chemical compound C1=C(OC)C(OC)=CC=C1C1CCC(=O)CC1 ZFNPIMGGFINZOM-UHFFFAOYSA-N 0.000 description 1
• LIAPPURFKRACQO-UHFFFAOYSA-N 4-(3-fluorophenyl)cyclohexan-1-one Chemical compound FC1=CC=CC(C2CCC(=O)CC2)=C1 LIAPPURFKRACQO-UHFFFAOYSA-N 0.000 description 1
• DWBASXJXOOJROY-UHFFFAOYSA-N 4-(3-methoxyphenyl)cyclohexan-1-one Chemical compound COC1=CC=CC(C2CCC(=O)CC2)=C1 DWBASXJXOOJROY-UHFFFAOYSA-N 0.000 description 1
• QMQMFUKUEXEZSI-UHFFFAOYSA-N 4-(3-methylphenyl)cyclohexan-1-one Chemical compound CC1=CC=CC(C2CCC(=O)CC2)=C1 QMQMFUKUEXEZSI-UHFFFAOYSA-N 0.000 description 1
• JNBOVWFOTNYTES-UHFFFAOYSA-N 4-(4-chlorophenyl)cyclohexan-1-one Chemical compound C1=CC(Cl)=CC=C1C1CCC(=O)CC1 JNBOVWFOTNYTES-UHFFFAOYSA-N 0.000 description 1
• XDHMORMQXOUOHT-UHFFFAOYSA-N 4-(4-methylphenyl)cyclohexan-1-one Chemical compound C1=CC(C)=CC=C1C1CCC(=O)CC1 XDHMORMQXOUOHT-UHFFFAOYSA-N 0.000 description 1
• XFRVACCGEKPJDI-UHFFFAOYSA-N 4-(4-oxocyclohexyl)benzonitrile Chemical compound C1CC(=O)CCC1C1=CC=C(C#N)C=C1 XFRVACCGEKPJDI-UHFFFAOYSA-N 0.000 description 1
• XFLMVUWRMQXZBZ-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)phenyl]cyclohexan-1-one Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C2CCC(=O)CC2)=C1 XFLMVUWRMQXZBZ-UHFFFAOYSA-N 0.000 description 1
• HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 1
• GKXOABVSZWCJJK-UHFFFAOYSA-N 4-oxo-1-phenylcyclohexane-1-carbonitrile Chemical compound C1CC(=O)CCC1(C#N)C1=CC=CC=C1 GKXOABVSZWCJJK-UHFFFAOYSA-N 0.000 description 1
• YKAYMASDSHFOGI-UHFFFAOYSA-N 4-phenylcyclohexan-1-one Chemical compound C1CC(=O)CCC1C1=CC=CC=C1 YKAYMASDSHFOGI-UHFFFAOYSA-N 0.000 description 1
• FPKISACHVIIMRA-UHFFFAOYSA-N 4-propan-2-ylcyclohexan-1-one Chemical compound CC(C)C1CCC(=O)CC1 FPKISACHVIIMRA-UHFFFAOYSA-N 0.000 description 1
• KHTYLZJZMBSTCN-UHFFFAOYSA-N 4-thiophen-2-ylcyclohexan-1-one Chemical compound C1CC(=O)CCC1C1=CC=CS1 KHTYLZJZMBSTCN-UHFFFAOYSA-N 0.000 description 1
• UZDSSCBDDNFAMZ-UHFFFAOYSA-N 5,6,7,8-tetrahydro-4h-[1,3]thiazolo[4,5-c]azepine Chemical group C1CCNCC2=C1SC=N2 UZDSSCBDDNFAMZ-UHFFFAOYSA-N 0.000 description 1
• UMWKPIKCOCKMIH-UHFFFAOYSA-N 5,6,7,8-tetrahydro-4h-cyclohepta[d][1,3]thiazole Chemical compound C1CCCCC2=C1SC=N2 UMWKPIKCOCKMIH-UHFFFAOYSA-N 0.000 description 1
• 125000006043 5-hexenyl group Chemical group 0.000 description 1
• NQKPKIZHPZWYJJ-UHFFFAOYSA-N 6-bromo-2,2-dimethylcyclohexan-1-one Chemical compound CC1(C)CCCC(Br)C1=O NQKPKIZHPZWYJJ-UHFFFAOYSA-N 0.000 description 1
• SNBBQEMJLGTFAH-UHFFFAOYSA-N 6-bromo-2-ethyl-2-methylcyclohexan-1-one Chemical compound CCC1(C)CCCC(Br)C1=O SNBBQEMJLGTFAH-UHFFFAOYSA-N 0.000 description 1
• NYORKTOSGYPYRJ-UHFFFAOYSA-N 6-bromo-2-methyl-2-(2-methylpropyl)cyclohexan-1-one Chemical compound CC(C)CC1(C)CCCC(Br)C1=O NYORKTOSGYPYRJ-UHFFFAOYSA-N 0.000 description 1
• WYMTYHBTAVGDFL-UHFFFAOYSA-N 6-bromo-2-methyl-2-propylcyclohexan-1-one Chemical compound CCCC1(C)CCCC(Br)C1=O WYMTYHBTAVGDFL-UHFFFAOYSA-N 0.000 description 1
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
• GNNFMZHECHAEGF-IHFUZBNMSA-N 99588-52-0 Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)CC1=CC=CC=C1 GNNFMZHECHAEGF-IHFUZBNMSA-N 0.000 description 1
• 108010004276 A18Famide Proteins 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
• 239000005711 Benzoic acid Substances 0.000 description 1
• SSWDYIISIMFHQP-UHFFFAOYSA-N C(C1=CC=CC=C1)N.C(C1=CC=CC=C1)NC(=S)N1CC2=C(CC1)N=C(S2)NC(=N)N Chemical compound C(C1=CC=CC=C1)N.C(C1=CC=CC=C1)NC(=S)N1CC2=C(CC1)N=C(S2)NC(=N)N SSWDYIISIMFHQP-UHFFFAOYSA-N 0.000 description 1
• GLYSMGFPLROUPN-UHFFFAOYSA-N CNCCC1=CC=CC=C1.NC(NC1=NC(C(CCC2)C(O)=O)=C2S1)=N Chemical compound CNCCC1=CC=CC=C1.NC(NC1=NC(C(CCC2)C(O)=O)=C2S1)=N GLYSMGFPLROUPN-UHFFFAOYSA-N 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 1
• 101710150887 Cholecystokinin A Proteins 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
• OUYCCCASQSFEME-MRVPVSSYSA-N D-tyrosine Chemical compound OC(=O)[C@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-MRVPVSSYSA-N 0.000 description 1
• YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
• QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
• 101800002230 FMRFamide-like Proteins 0.000 description 1
• PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
• XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
• 101001123492 Homo sapiens Prolactin-releasing peptide receptor Proteins 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• 206010065390 Inflammatory pain Diseases 0.000 description 1
• 241000581650 Ivesia Species 0.000 description 1
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
• 101150009512 NPVF gene Proteins 0.000 description 1
• 102000003797 Neuropeptides Human genes 0.000 description 1
• PWHVEHULNLETOV-UHFFFAOYSA-N Nic-1 Natural products C12OC2C2(O)CC=CC(=O)C2(C)C(CCC2=C3)C1C2=CC=C3C(C)C1OC(O)C2(C)OC2(C)C1 PWHVEHULNLETOV-UHFFFAOYSA-N 0.000 description 1
• GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
• CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
• 241001440143 Panula Species 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 108010043958 Peptoids Proteins 0.000 description 1
• 102100029002 Prolactin-releasing peptide receptor Human genes 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
• 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
• FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
• XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
• DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
• 125000001539 acetonyl group Chemical group [H]C([H])([H])C(=O)C([H])([H])* 0.000 description 1
• 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
• 150000008065 acid anhydrides Chemical class 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 125000002252 acyl group Chemical group 0.000 description 1
• 210000001789 adipocyte Anatomy 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 150000001298 alcohols Chemical class 0.000 description 1
• 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
• 229910052783 alkali metal Inorganic materials 0.000 description 1
• 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
• 150000001340 alkali metals Chemical class 0.000 description 1
• 150000001342 alkaline earth metals Chemical class 0.000 description 1
• 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 1
• 125000000278 alkyl amino alkyl group Chemical group 0.000 description 1
• 125000004949 alkyl amino carbonyl amino group Chemical group 0.000 description 1
• 125000004457 alkyl amino carbonyl group Chemical group 0.000 description 1
• 125000004947 alkyl aryl amino group Chemical group 0.000 description 1
• 125000005907 alkyl ester group Chemical group 0.000 description 1
• 125000004422 alkyl sulphonamide group Chemical group 0.000 description 1
• 208000026935 allergic disease Diseases 0.000 description 1
• HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
• 125000000266 alpha-aminoacyl group Chemical group 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
• 150000008064 anhydrides Chemical class 0.000 description 1
• 230000008485 antagonism Effects 0.000 description 1
• 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
• 201000007201 aphasia Diseases 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• 125000005100 aryl amino carbonyl group Chemical group 0.000 description 1
• 125000001769 aryl amino group Chemical group 0.000 description 1
• 125000005129 aryl carbonyl group Chemical group 0.000 description 1
• 125000005160 aryl oxy alkyl group Chemical group 0.000 description 1
• 125000004421 aryl sulphonamide group Chemical group 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• 238000000376 autoradiography Methods 0.000 description 1
• RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
• 229910001863 barium hydroxide Inorganic materials 0.000 description 1
• 230000004888 barrier function Effects 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
• 235000010233 benzoic acid Nutrition 0.000 description 1
• 229960004365 benzoic acid Drugs 0.000 description 1
• 125000000638 benzylaminocarbonyl group Chemical group C(C1=CC=CC=C1)NC(=O)* 0.000 description 1
• KUWBXRGRMQZCSS-HSZRJFAPSA-N bibp-3226 Chemical compound N([C@H](CCCN=C(N)N)C(=O)NCC=1C=CC(O)=CC=1)C(=O)C(C=1C=CC=CC=1)C1=CC=CC=C1 KUWBXRGRMQZCSS-HSZRJFAPSA-N 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 239000004305 biphenyl Substances 0.000 description 1
• 235000010290 biphenyl Nutrition 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 239000001273 butane Substances 0.000 description 1
• KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
• NRDQFWXVTPZZAZ-UHFFFAOYSA-N butyl carbonochloridate Chemical compound CCCCOC(Cl)=O NRDQFWXVTPZZAZ-UHFFFAOYSA-N 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910000019 calcium carbonate Inorganic materials 0.000 description 1
• 229930003827 cannabinoid Natural products 0.000 description 1
• 239000003557 cannabinoid Substances 0.000 description 1
• 229940065144 cannabinoids Drugs 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 239000004202 carbamide Substances 0.000 description 1
• 125000002837 carbocyclic group Chemical group 0.000 description 1
• 150000001718 carbodiimides Chemical class 0.000 description 1
• CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
• 229950005499 carbon tetrachloride Drugs 0.000 description 1
• 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
• MOIPGXQKZSZOQX-UHFFFAOYSA-N carbonyl bromide Chemical compound BrC(Br)=O MOIPGXQKZSZOQX-UHFFFAOYSA-N 0.000 description 1
• 150000001728 carbonyl compounds Chemical class 0.000 description 1
• PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
• 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
• 239000003054 catalyst Substances 0.000 description 1
• 239000006143 cell culture medium Substances 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 210000001638 cerebellum Anatomy 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
• 239000000460 chlorine Substances 0.000 description 1
• 229910052801 chlorine Inorganic materials 0.000 description 1
• FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
• 229960001701 chloroform Drugs 0.000 description 1
• 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
• 229960004106 citric acid Drugs 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 229940125898 compound 5 Drugs 0.000 description 1
• 238000002425 crystallisation Methods 0.000 description 1
• 230000008025 crystallization Effects 0.000 description 1
• 238000011461 current therapy Methods 0.000 description 1
• 125000006310 cycloalkyl amino group Chemical group 0.000 description 1
• 125000005167 cycloalkylaminocarbonyl group Chemical group 0.000 description 1
• 125000005170 cycloalkyloxycarbonyl group Chemical group 0.000 description 1
• 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• FWFSEYBSWVRWGL-UHFFFAOYSA-N cyclohex-2-enone Chemical compound O=C1CCCC=C1 FWFSEYBSWVRWGL-UHFFFAOYSA-N 0.000 description 1
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 108010010973 desamino-tyrosyl-phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-argininamide Proteins 0.000 description 1
• 229910052805 deuterium Inorganic materials 0.000 description 1
• 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 1
• 125000004473 dialkylaminocarbonyl group Chemical group 0.000 description 1
• 125000004986 diarylamino group Chemical group 0.000 description 1
• HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
• 229940043279 diisopropylamine Drugs 0.000 description 1
• BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 1
• 125000006222 dimethylaminomethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])* 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 239000008298 dragée Substances 0.000 description 1
• 239000003480 eluent Substances 0.000 description 1
• 238000004146 energy storage Methods 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 150000002170 ethers Chemical class 0.000 description 1
• FGSGHBPKHFDJOP-UHFFFAOYSA-N ethyl 2-oxocyclohexane-1-carboxylate Chemical compound CCOC(=O)C1CCCCC1=O FGSGHBPKHFDJOP-UHFFFAOYSA-N 0.000 description 1
• SFLPOCDMLNCXLK-UHFFFAOYSA-N ethyl 3-bromo-4-oxo-1-phenylcyclohexane-1-carboxylate Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCC(=O)C(Br)C1 SFLPOCDMLNCXLK-UHFFFAOYSA-N 0.000 description 1
• IGOWSOGBQMBHIY-UHFFFAOYSA-N ethyl 3-bromo-4-oxocyclohexane-1-carboxylate Chemical compound CCOC(=O)C1CCC(=O)C(Br)C1 IGOWSOGBQMBHIY-UHFFFAOYSA-N 0.000 description 1
• SYBVWVIZANWJOR-UHFFFAOYSA-N ethyl 4-oxo-1-phenylcyclohexane-1-carboxylate Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCC(=O)CC1 SYBVWVIZANWJOR-UHFFFAOYSA-N 0.000 description 1
• ZXYAWONOWHSQRU-UHFFFAOYSA-N ethyl 4-oxocyclohexanecarboxylate Chemical compound CCOC(=O)C1CCC(=O)CC1 ZXYAWONOWHSQRU-UHFFFAOYSA-N 0.000 description 1
• AFRWBGJRWRHQOV-UHFFFAOYSA-N ethyl 5-bromopentanoate Chemical compound CCOC(=O)CCCCBr AFRWBGJRWRHQOV-UHFFFAOYSA-N 0.000 description 1
• 125000006260 ethylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])C([H])([H])[H] 0.000 description 1
• 125000006125 ethylsulfonyl group Chemical group 0.000 description 1
• 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
• 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
• 238000002474 experimental method Methods 0.000 description 1
• 239000012467 final product Substances 0.000 description 1
• 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
• 239000011737 fluorine Substances 0.000 description 1
• 229910052731 fluorine Inorganic materials 0.000 description 1
• FATAVLOOLIRUNA-UHFFFAOYSA-N formylmethyl Chemical group [CH2]C=O FATAVLOOLIRUNA-UHFFFAOYSA-N 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• 125000002541 furyl group Chemical group 0.000 description 1
• 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 1
• 229940052308 general anesthetics halogenated hydrocarbons Drugs 0.000 description 1
• 125000004992 haloalkylamino group Chemical group 0.000 description 1
• 150000008282 halocarbons Chemical class 0.000 description 1
• 125000005843 halogen group Chemical group 0.000 description 1
• 230000026030 halogenation Effects 0.000 description 1
• 238000005658 halogenation reaction Methods 0.000 description 1
• 125000005241 heteroarylamino group Chemical group 0.000 description 1
• 125000005222 heteroarylaminocarbonyl group Chemical group 0.000 description 1
• 125000005842 heteroatom Chemical group 0.000 description 1
• GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
• 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
• 230000003054 hormonal effect Effects 0.000 description 1
• 150000004678 hydrides Chemical class 0.000 description 1
• 229930195733 hydrocarbon Natural products 0.000 description 1
• QWMUDOFWQWBHFI-UHFFFAOYSA-N hydroxy-imino-diphenoxy-$l^{5}-phosphane Chemical compound C=1C=CC=CC=1OP(=O)(N)OC1=CC=CC=C1 QWMUDOFWQWBHFI-UHFFFAOYSA-N 0.000 description 1
• 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
• 230000009610 hypersensitivity Effects 0.000 description 1
• 210000003016 hypothalamus Anatomy 0.000 description 1
• 125000002632 imidazolidinyl group Chemical group 0.000 description 1
• 125000002636 imidazolinyl group Chemical group 0.000 description 1
• 125000002883 imidazolyl group Chemical group 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 125000004129 indan-1-yl group Chemical group [H]C1=C([H])C([H])=C2C(=C1[H])C([H])([H])C([H])([H])C2([H])* 0.000 description 1
• 125000001041 indolyl group Chemical group 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 238000000185 intracerebroventricular administration Methods 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 239000011630 iodine Substances 0.000 description 1
• 229910052740 iodine Inorganic materials 0.000 description 1
• HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
• INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
• 239000003456 ion exchange resin Substances 0.000 description 1
• 229920003303 ion-exchange polymer Polymers 0.000 description 1
• 125000001977 isobenzofuranyl group Chemical group C=1(OC=C2C=CC=CC12)* 0.000 description 1
• 125000005990 isobenzothienyl group Chemical group 0.000 description 1
• 239000012948 isocyanate Substances 0.000 description 1
• 150000002513 isocyanates Chemical class 0.000 description 1
• 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
• JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
• 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
• 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
• 125000001786 isothiazolyl group Chemical group 0.000 description 1
• 150000002540 isothiocyanates Chemical class 0.000 description 1
• 125000000842 isoxazolyl group Chemical group 0.000 description 1
• 150000002576 ketones Chemical class 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 238000012417 linear regression Methods 0.000 description 1
• 229910052744 lithium Inorganic materials 0.000 description 1
• YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
• 159000000003 magnesium salts Chemical class 0.000 description 1
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
• 239000011976 maleic acid Substances 0.000 description 1
• 229960002510 mandelic acid Drugs 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 229940098779 methanesulfonic acid Drugs 0.000 description 1
• QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
• 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
• 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
• 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
• 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 description 1
• 150000007522 mineralic acids Chemical class 0.000 description 1
• 208000008013 morphine dependence Diseases 0.000 description 1
• 125000002757 morpholinyl group Chemical group 0.000 description 1
• IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
• 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
• 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• PVWOIHVRPOBWPI-UHFFFAOYSA-N n-propyl iodide Chemical compound CCCI PVWOIHVRPOBWPI-UHFFFAOYSA-N 0.000 description 1
• 125000001624 naphthyl group Chemical group 0.000 description 1
• BPGXUIVWLQTVLZ-OFGSCBOVSA-N neuropeptide y(npy) Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 BPGXUIVWLQTVLZ-OFGSCBOVSA-N 0.000 description 1
• 239000002858 neurotransmitter agent Substances 0.000 description 1
• 229910017604 nitric acid Inorganic materials 0.000 description 1
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
• LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
• 230000003040 nociceptive effect Effects 0.000 description 1
• 239000003399 opiate peptide Substances 0.000 description 1
• 238000005457 optimization Methods 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 150000007524 organic acids Chemical class 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 125000001715 oxadiazolyl group Chemical group 0.000 description 1
• 235000006408 oxalic acid Nutrition 0.000 description 1
• 125000000160 oxazolidinyl group Chemical group 0.000 description 1
• 125000005968 oxazolinyl group Chemical group 0.000 description 1
• 125000002971 oxazolyl group Chemical group 0.000 description 1
• FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
• XGISHOFUAFNYQF-UHFFFAOYSA-N pentanoyl chloride Chemical compound CCCCC(Cl)=O XGISHOFUAFNYQF-UHFFFAOYSA-N 0.000 description 1
• 108010091748 peptide A Proteins 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 239000003208 petroleum Substances 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 125000005561 phenanthryl group Chemical group 0.000 description 1
• DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 125000003386 piperidinyl group Chemical group 0.000 description 1
• 229920000768 polyamine Polymers 0.000 description 1
• NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
• 229910000105 potassium hydride Inorganic materials 0.000 description 1
• BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 239000002244 precipitate Substances 0.000 description 1
• 238000002953 preparative HPLC Methods 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 150000003141 primary amines Chemical class 0.000 description 1
• BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
• UFUASNAHBMBJIX-UHFFFAOYSA-N propan-1-one Chemical group CC[C]=O UFUASNAHBMBJIX-UHFFFAOYSA-N 0.000 description 1
• DRINJBFRTLBHNF-UHFFFAOYSA-N propane-2-sulfonyl chloride Chemical compound CC(C)S(Cl)(=O)=O DRINJBFRTLBHNF-UHFFFAOYSA-N 0.000 description 1
• 235000019260 propionic acid Nutrition 0.000 description 1
• 102000004169 proteins and genes Human genes 0.000 description 1
• 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
• 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
• 125000001422 pyrrolinyl group Chemical group 0.000 description 1
• 125000000168 pyrrolyl group Chemical group 0.000 description 1
• 229940107700 pyruvic acid Drugs 0.000 description 1
• IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
• 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
• 239000002287 radioligand Substances 0.000 description 1
• 230000009257 reactivity Effects 0.000 description 1
• 238000010992 reflux Methods 0.000 description 1
• 230000010656 regulation of insulin secretion Effects 0.000 description 1
• 239000011347 resin Substances 0.000 description 1
• 229920005989 resin Polymers 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 125000006413 ring segment Chemical group 0.000 description 1
• 229960004889 salicylic acid Drugs 0.000 description 1
• 238000007127 saponification reaction Methods 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 229910000077 silane Inorganic materials 0.000 description 1
• 239000001632 sodium acetate Substances 0.000 description 1
• 235000017281 sodium acetate Nutrition 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• 239000012312 sodium hydride Substances 0.000 description 1
• 229910000104 sodium hydride Inorganic materials 0.000 description 1
• 235000009518 sodium iodide Nutrition 0.000 description 1
• 235000010265 sodium sulphite Nutrition 0.000 description 1
• 238000000935 solvent evaporation Methods 0.000 description 1
• 230000009870 specific binding Effects 0.000 description 1
• 125000003003 spiro group Chemical group 0.000 description 1
• 238000006467 substitution reaction Methods 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical compound [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
• 150000003461 sulfonyl halides Chemical class 0.000 description 1
• 229910052717 sulfur Inorganic materials 0.000 description 1
• 239000011593 sulfur Substances 0.000 description 1
• YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 239000003826 tablet Substances 0.000 description 1
• 235000002906 tartaric acid Nutrition 0.000 description 1
• 239000011975 tartaric acid Substances 0.000 description 1
• 229960001367 tartaric acid Drugs 0.000 description 1
• RGWGRRBHQUREDE-UHFFFAOYSA-N tert-butyl 3-bromo-4-oxopiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(=O)C(Br)C1 RGWGRRBHQUREDE-UHFFFAOYSA-N 0.000 description 1
• ROUYFJUVMYHXFJ-UHFFFAOYSA-N tert-butyl 4-oxopiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(=O)CC1 ROUYFJUVMYHXFJ-UHFFFAOYSA-N 0.000 description 1
• NBRKLOOSMBRFMH-UHFFFAOYSA-N tert-butyl chloride Chemical compound CC(C)(C)Cl NBRKLOOSMBRFMH-UHFFFAOYSA-N 0.000 description 1
• VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
• 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
• 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
• 125000005958 tetrahydrothienyl group Chemical group 0.000 description 1
• CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
• 125000001113 thiadiazolyl group Chemical group 0.000 description 1
• 125000001984 thiazolidinyl group Chemical group 0.000 description 1
• 125000002769 thiazolinyl group Chemical group 0.000 description 1
• 125000000335 thiazolyl group Chemical group 0.000 description 1
• 125000001544 thienyl group Chemical group 0.000 description 1
• 125000004001 thioalkyl group Chemical group 0.000 description 1
• 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
• XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
• 125000005147 toluenesulfonyl group Chemical group C=1(C(=CC=CC1)S(=O)(=O)*)C 0.000 description 1
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• LALRXNPLTWZJIJ-UHFFFAOYSA-N triethylborane Chemical compound CCB(CC)CC LALRXNPLTWZJIJ-UHFFFAOYSA-N 0.000 description 1
• IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 1
• 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
• 239000005051 trimethylchlorosilane Substances 0.000 description 1
• YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
• TVXYIDHQHDNHCZ-UHFFFAOYSA-N undecan-1-one Chemical compound CCCCCCCCCC[C]=O TVXYIDHQHDNHCZ-UHFFFAOYSA-N 0.000 description 1
• 238000005292 vacuum distillation Methods 0.000 description 1
• 239000008096 xylene Substances 0.000 description 1